FDA Office of New Drug Chemistry
Executive Summary
Oncology Drug Products Division Chemistry Team Leader Eric Duffy, PhD, becomes Division of New Drug Chemistry II director July 8. Duffy "has a particular interest in drug substance manufacturing issues and is a past chair of the Drug Substance Committee," FDA says. He is also involved in the new initiative for risk-management-based chemistry, manufacturing and control review (1"The Pink Sheet" June 25, p. 32)